Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

Genus reports strong profit and cash flow growth, stock falls pre-market

Genus reported an adjusted pre-tax profit of £100.2m and adjusted EPS of 110.3p for H2 2026—both up 35%—with free cash flow of £62m. Reported revenue fell 2% to £658.1m, mainly due to the deconsolidation of PIC China. The company expects moderate profit growth in 2027, weighted to the second half, and announced a 10% dividend increase to 35.2p plus a £60m share buyback programme. Despite improved profitability, the stock fell 6.65% pre-market as investors weighed the revenue decline, the H2‑weighted outlook and regional headwinds more heavily. » Altro su de.investing.com
Genus falls after revenue miss and cautious outlook

Genus shares fell 6.5% after preliminary results for 2026 showed adjusted revenue down 2% to £658.1m, missing consensus. The decline in revenue was mainly due to the deconsolidation of PIC China following the formation of a joint venture with Beijing Capital Agribusiness. Positive: adjusted operating profit rose 25% to £116.0m and adjusted pre-tax profit rose 35% to £100.2m, supported by strong PIC growth and a £5.6m milestone payment. Genus announced a £60m share buyback programme but warned adjusted pre-tax earnings for 2027 are likely to be weighted heavily to the second half due to disease-related issues in North American pig production and lower hog and milk prices. » Altro su de.investing.com
Genus increases profit forecast for FY26 to around £98m and shares rise

Genus forecasts an adjusted pre-tax profit of around £98m for fiscal 2026, beating consensus estimates. The positive revision reflects a stronger-than-expected second half, with robust growth in the pig genetics business (PIC) in Asia and Latin America and double-digit profit growth at the cattle genetics division (ABS) thanks to the Value Acceleration Programme. The company also reports very strong cash conversion, material free cash flow growth and a strengthened balance sheet heading into FY27. The shares rose sharply intraday and closed well above the prior level. » Altro su de.investing.com

Dividendi storici Dividendi

Tutte le metriche sui dividendi Tutte le metriche

Nel 2026, GENUS ha già distribuito 0,13 € di dividendi. L'ultimo pagamento è avvenuto a marzo.

Dati finanziari dell'azienda

Nell'ultimo trimestre, GENUS ha registrato ricavi pari a 362,11 Mln € e un utile netto di 291,25 Mln €

(EUR)	giugno 2026	YoY
Ricavi	362,11 Mln	-
Utile lordo	0	-
Utile netto	291,25 Mln	-
EBITDA	79,8 Mln	-

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	1,69 Mld €
Numero di azioni	66,41 Mln
Massimo/minimo a 52 settimane	32,73 € - 25,04 €
Rendimento da dividendo	1,54%
Dividendi TTM	0,38 €
Beta	0,90
Rapporto P/E	4,88
Rapporto PEG	0,00
Rapporto P/B	1,82
Rapporto P/S	2,11

Profilo aziendale

Genus plc ist als Tiergenetik-Unternehmen in Nordamerika, Lateinamerika, dem Vereinigten Königreich, dem übrigen Europa, dem Nahen Osten, Russland, Afrika und Asien tätig. Das Unternehmen ist in drei Segmenten tätig: Genus PIC, Genus ABS und Genus Forschung und Entwicklung. Unter der Marke PIC verkauft es Sauen, Eber und Sperma für die Zucht von Schweinen mit verschiedenen Eigenschaften für die Schweinefleischproduktion. Unter den Marken ABS, Genus und Bovec vertreibt das Unternehmen außerdem Bullensperma und Embryonen zur Aufzucht von Kälbern mit verschiedenen Merkmalen für die Milch- und Rindfleischproduktion. Darüber hinaus bietet das Unternehmen Landwirten die Geschlechtsbestimmung von Samen, Fortpflanzung und andere technische Dienstleistungen an. Genus plc hat eine strategische Zusammenarbeit mit Beijing Capital Agribusiness Co. Ltd. eine strategische Zusammenarbeit, um die Regulierungs- und Entwicklungsarbeit im Bereich der Resistenz gegen das porcine reproduktive respiratorische Syndrom in China voranzutreiben. Das Unternehmen wurde 1994 gegründet und hat seinen Sitz in Basingstoke, Vereinigtes Königreich.